Antigens for cancer immunotherapy

被引：127
作者：
Neller, Michelle A. [1 ,2 ]
Lopez, J. Alejandro [1 ,2 ,3 ]
Schmidt, Christopher W. [1 ]
机构：
[1] Queensland Inst Med Res, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Sch Med, Herston, Qld 4006, Australia
[3] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia
来源：
SEMINARS IN IMMUNOLOGY | 2008年 / 20卷 / 05期
基金：
英国医学研究理事会;
关键词：
Cancer; Immunotherapy; Antigen; Tolerance; Clinical trial;
D O I：
10.1016/j.smim.2008.09.006
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Progress in tumor immunology has not been translated to effective immunotherapies for cancer. Most of the current effort in basic and clinical research concentrates on generating effective immune responses against model or well characterized antigens, yet vaccines targeting defined antigens have been less clinically successful than those based on whole tumor cells or their extracts. This review considers characteristics of proteins that determine how effectively they might serve as targets of immune control, and how different sources of antigens have fared in clinical trials. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：286 / 295
页数：10
相关论文
共 50 条
[31]   Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma [J].
Zhuo, Shenghua ;
Yang, Shuo ;
Chen, Shenbo ;
Ding, Yueju ;
Cheng, Honglei ;
Yang, Liangwang ;
Wang, Kai ;
Yang, Kun .
DISCOVER ONCOLOGY, 2024, 15 (01)
[32]   α-Fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer [J].
Evdokimova, Viktoria N. ;
Butterfield, Lisa H. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (03) :325-336
[33]   Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease [J].
Brichard, Vincent G. ;
Lejeune, Diane .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (07) :951-968
[34]   Dendritic Cells in Cancer Immunology and Immunotherapy [J].
Hato, Laura ;
Vizcay, Angel ;
Eguren, Inaki ;
Perez-Gracia, Jose L. ;
Rodriguez, Javier ;
Perez-Larraya, Jaime Gallego ;
Sarobe, Pablo ;
Inoges, Susana ;
de Cerio, Ascension Lopez Diaz ;
Santisteban, Marta .
CANCERS, 2024, 16 (05)
[35]   Instigation of the epoch of nanovaccines in cancer immunotherapy [J].
Shah, Saurabh ;
Famta, Paras ;
Tiwari, Vinod ;
Kotha, Arun K. ;
Kashikar, Rama ;
Chougule, Mahavir Bhupal ;
Chung, Young Hun ;
Steinmetz, Nicole F. ;
Uddin, Mohammad ;
Singh, Shashi Bala ;
Srivastava, Saurabh .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2023, 15 (03)
[36]   Cancer immunotherapy of patients with HIV infection [J].
Gonzalez-Cao, M. ;
Martinez-Picado, J. ;
Karachaliou, N. ;
Rosell, R. ;
Meyerhans, A. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (06) :713-720
[37]   Experimental vaccine strategies for cancer immunotherapy [J].
Chen, CH ;
Wu, TC .
JOURNAL OF BIOMEDICAL SCIENCE, 1998, 5 (04) :231-252
[38]   The Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy [J].
Kye, Yae ;
Nagineni, Lokesh ;
Gadad, Shrikanth ;
Ramirez, Fabiola ;
Riva, Hannah ;
Fernandez, Lorena ;
Samaniego, Michelle ;
Holland, Nathan ;
Yeh, Rose ;
Takigawa, Kei ;
Dhandayuthapani, Subramanian ;
Chacon, Jessica .
CANCERS, 2022, 14 (17)
[39]   CANCER IMMUNOTHERAPY [J].
Quintin-Colonna, Francoise ;
Montier, Yves ;
Pere, Helene ;
Sandoval, Federico ;
Merillon, Nathalie ;
Freyburger, Ludovic ;
Adotevi, Olivier ;
Tartour, Eric .
BULLETIN DE L ACADEMIE VETERINAIRE DE FRANCE, 2010, 163 (04) :363-U172
[40]   Cancer Immunotherapy [J].
White, Richard L., Jr. ;
Amin, Asim .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 20 (03) :531-+
12345